Search

Your search keyword '"Gina M. Mantia-Smaldone"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Gina M. Mantia-Smaldone" Remove constraint Author: "Gina M. Mantia-Smaldone"
25 results on '"Gina M. Mantia-Smaldone"'

Search Results

1. Perceived importance of weight loss and exercise among endometrial cancer survivors with overweight or obesity: Implications for lifestyle modification interventions

2. Non-Gestational Ovarian Choriocarcinoma: A Rare Ovarian Cancer Subtype

Catalog

Books, media, physical & digital resources

3. Data from Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens

4. Supplementary Materials, Methods, Figures and Table legends from A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

5. Supplementary Figure S2 from A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

6. Supplementary Table S1 from A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

7. Data from A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

8. Supplementary File 3 from Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens

9. Supplementary File 1 from Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens

10. Supplementary Figures from Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens

11. Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

12. Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

13. Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer

14. Is there a benefit to delaying cholecystectomy for symptomatic gallbladder disease during pregnancy?

15. Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab

16. A review of dendritic cell therapy for cancer: progress and challenges

17. A dendritic cell vaccine pulsed with autologous hypochlorous Acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside

18. Immunotherapy in ovarian cancer

19. Preventive Strategies in Epithelial Ovarian Cancer

20. Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

21. Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer

22. Pregnancy outcomes after conservative surgical management of ovarian neoplasms treated at a single institution

23. Cervical cancer and risk for delivery of small-for-gestational age neonates

24. Pregnancy after tumor debulking and intraperitoneal cisplatin for appendiceal carcinoid tumor